Liraglutide vs Semaglutide: Complete 2026 Comparison
Side-by-side comparison of Liraglutide and Semaglutide: mechanism, common use cases, dosing protocols from named experts, vendor availability, and expert opinion. Both are framed as research compounds.
TL;DR Table
| Factor | Liraglutide | Semaglutide |
|---|---|---|
| Class | PEPTIDE | PEPTIDE |
| Aliases | [] | ["Ozempic"] |
| Mechanism | n/a | n/a |
| What it's researched for | Early-generation single GLP-1 receptor agonist; daily dosing allowed off-day refeeds. | Single GLP-1 receptor agonist that suppresses appetite; the first widely-used GLP-1 in this class. |
| Dosing mentions tracked | 6 | 33 |
| Vendor recs tracked | 0 | 3 |
| PubMed papers | 15 | 15 |
Mechanism Comparison
What Each is Researched For
Liraglutide research areas
Early-generation single GLP-1 receptor agonist; daily dosing allowed off-day refeeds.
Semaglutide research areas
Single GLP-1 receptor agonist that suppresses appetite; the first widely-used GLP-1 in this class.
Dosing Mention Comparison
Liraglutide dosing
- Vigorous Steve: 5-6 days a week with Saturday/Sunday off for refeed (00:07:16)
- Vigorous Steve: Daily injection Mon-Sat, off Sunday for refeed day; or 0.6-1.2 mg/day on demand as appetite-suppression rescue alongside retatrutide (00:15:18)
- Steve: Steve reported using daily injections Monday-Saturday, with Sunday off as a refeed day, and described an acute appetite-control dose of... (00:15:18)
- Steve: Steve reported using 0.6 to 1.2 mg daily to support appetite suppression when stacked with retatrutide. (01:52:56)
- Vigorous Steve: 0.6-1.2 mg as needed for spike appetite suppression alongside retatrutide (01:52:57)
Semaglutide dosing
- Speaker 1: Speaker 1 reported that when experiencing nausea or intolerance, they did not increase the dose and instead reduced to the lowest... (00:00:01)
- speakerHint: Speaker says they observed people using the lowest dose reporting positive experiences, suggesting dosing responses may vary based on... (00:00:14)
- Host: The Host recommended a gradual introduction protocol, starting with intentionally small doses to minimize GI side effects (nausea,... (00:00:24)
- speakerHint: Speaker emphasizes finding an individual dosing window rather than choosing based on molecule; too low leaves food noise high, too high... (00:00:24)
- speaker_0: Vial concentration described as 1 ml liquid semaglutide containing 2.5 mg semaglutide per ml. (00:00:32)
Side Effect Notes
Anecdotal reports for both compounds vary by route, dose, and individual. Neither should be treated as an approved medication. Consult a qualified clinician.
When To Choose Which
Comparison depends on research question, available source quality, and individual risk tolerance. See the full profiles for Liraglutide and Semaglutide for context-specific details.
Can You Stack Them?
Stacking decisions should be evaluated by qualified professionals with attention to dose attribution, source quality, and outcome tracking. This page is a research aggregator and does not recommend stacking protocols.
FAQ
Which has more research?
Liraglutide has 15 PubMed citations indexed; Semaglutide has 15.
Which has more vendor coverage?
Liraglutide: 0 tracked vendor recommendations. Semaglutide: 3.
Are they approved drugs?
Both are framed on this site as research compounds. Verify current FDA status and state-specific rules before any decision.
Where do I read more?
See Liraglutide and Semaglutide for full profiles with all dosing mentions and PubMed citations.